title: Roflumilast, a Novel Phosphodiesterase 4 Inhibitor, for COPD Patients with a History of Exacerbations.
abstract: Acute exacerbations of COPD (AECOPD) are major clinical events. They are associated with a more rapid decline in lung function, poorer quality of life scores, and an increased risk of dying. Exacerbations that require hospitalization have particular significance. Approximately 40% of the AECOPD patients who require hospitalization will die in the subsequent year. Since many AECOPD require hospitalization, they account for most of the expense of caring for COPD patients. Treatment with long-acting bronchodilators and combination inhaled corticosteroid/long-acting bronchodilator inhalers reduces but does not eliminate AECOPD. Roflumilast, a selective phosphodiesterase 4 (PDE4) inhibitor, is an anti-inflammatory medication that improves lung function in patients with COPD. In patients with more severe airway obstruction, clinical features of chronic bronchitis, and a history of AECOPD, roflumilast reduces the frequency of AECOPD when given in combination with short-acting bronchodilators, long-acting bronchodilators, or inhaled corticosteroids. It is generally well tolerated but the most common adverse effects include diarrhea, nausea, weight loss, and headaches. In clinical trials, patients treated with roflumilast experienced weight loss that averaged just over 2 kg but was primarily due to the loss of fat tissue. Weight loss was least in underweight patients and obese patients experienced the greatest weight loss. An unexpected benefit of treatment with roflumilast was that fasting blood glucose and hemoglobin A1c levels improved in patients with comorbid type 2 diabetes mellitus. Roflumilast, the first selective PDE4 inhibitor to be marketed, is a promising drug for the management of COPD patients with more severe disease.
authors.affiliation: Division of Respiratory Medicine, University of Calgary, Calgary, Alberta, Canada.
authors.forename: Stephen K
authors.initials: SK
authors.lastname: Field
references.citation: Chest. 2010 Jul;138(1):3-6
references.pmid: 20605806
references.citation: Thorax. 2005 Jun;60(6):480-7
references.pmid: 15923248
references.citation: Chest. 2009 Apr;135(4):975-982
references.pmid: 19017866
references.citation: Lancet. 2003 Feb 8;361(9356):449-56
references.pmid: 12583942
references.citation: Drug Des Devel Ther. 2010 Jul 21;4:147-58
references.pmid: 20689641
references.citation: Eur Respir J. 2004 Mar;23(3):391-5
references.pmid: 15065827
references.citation: J Pharmacol Exp Ther. 2001 Apr;297(1):267-79
references.pmid: 11259554
references.citation: Lancet. 2007 Sep 1;370(9589):786-96
references.pmid: 17765528
references.citation: N Engl J Med. 2010 Sep 16;363(12):1128-38
references.pmid: 20843247
references.citation: Eur Respir J. 2011 Mar;37(3):508-15
references.pmid: 20595157
references.citation: Thorax. 2006 Sep;61(9):742-4
references.pmid: 16936233
references.citation: N Engl J Med. 2008 Oct 9;359(15):1543-54
references.pmid: 18836213
references.citation: Am J Respir Crit Care Med. 1998 Feb;157(2):351-70
references.pmid: 9476844
references.citation: Am J Respir Crit Care Med. 2005 Oct 1;172(7):848-53
references.pmid: 15961691
references.citation: Eur Respir J. 2009 May;33(5):1165-85
references.pmid: 19407051
references.citation: Pharmacol Rev. 2006 Sep;58(3):488-520
references.pmid: 16968949
references.citation: Am J Respir Crit Care Med. 2008 Jan 1;177(1):19-26
references.pmid: 17916806
references.citation: Lancet. 1998 Mar 14;351(9105):773-80
references.pmid: 9519948
references.citation: Thorax. 2005 Dec;60(12):992-7
references.pmid: 16227327
references.citation: Am J Respir Crit Care Med. 2003 Jul 1;168(1):49-53
references.pmid: 12663327
references.citation: Drugs. 2003;63(23):2575-94
references.pmid: 14636078
references.citation: Am J Respir Crit Care Med. 2004 Feb 15;169(4):448-53
references.pmid: 14597486
references.citation: Lancet. 2005 Aug 13-19;366(9485):563-71
references.pmid: 16099292
references.citation: Am J Respir Crit Care Med. 2007 Jul 15;176(2):162-6
references.pmid: 17400730
references.citation: Lancet. 2009 Aug 29;374(9691):695-703
references.pmid: 19716961
references.citation: Ann Intern Med. 1987 Feb;106(2):196-204
references.pmid: 3492164
references.citation: Am J Respir Cell Mol Biol. 2009 Dec;41(6):631-8
references.pmid: 19717810
references.citation: Eur Respir J. 2008 May;31(5):927-33
references.pmid: 18216056
references.citation: Am J Respir Crit Care Med. 2001 Aug 15;164(4):580-4
references.pmid: 11520719
references.citation: Respiration. 2000;67(5):495-501
references.pmid: 11070451
references.citation: Lancet. 2005 Jan 8-14;365(9454):167-75
references.pmid: 15639300
references.citation: N Engl J Med. 2007 Feb 22;356(8):775-89
references.pmid: 17314337
references.citation: Br J Clin Pharmacol. 2009 Oct;68(4):580-7
references.pmid: 19843061
references.citation: Thorax. 2002 Oct;57(10):847-52
references.pmid: 12324669
references.citation: Lancet. 1999 May 29;353(9167):1819-23
references.pmid: 10359405
references.citation: Pulm Pharmacol Ther. 2006;19(5):343-52
references.pmid: 16257550
references.citation: Respir Res. 2011 Jan 27;12:18
references.pmid: 21272339
references.citation: Am J Respir Crit Care Med. 1998 Mar;157(3 Pt 1):822-6
references.pmid: 9517597
references.citation: N Engl J Med. 2004 Jun 24;350(26):2645-53
references.pmid: 15215480
references.citation: Br J Pharmacol. 2007 Oct;152(4):481-92
references.pmid: 17704822
references.citation: BMC Pulm Med. 2008 Aug 28;8:17
references.pmid: 18755021
references.citation: Eur Respir J. 2003 Jan;21(1):74-81
references.pmid: 12570112
references.citation: Chest. 2007 Jan;131(1):20-8
references.pmid: 17218552
references.citation: N Engl J Med. 2002 Aug 15;347(7):465-71
references.pmid: 12181400
references.citation: Lancet. 2007 Sep 1;370(9589):774-85
references.pmid: 17765527
references.citation: BMJ. 2000 May 13;320(7245):1297-303
references.pmid: 10807619
references.citation: Eur Respir J. 2008 Apr;31(4):869-73
references.pmid: 18216052
references.citation: Am J Respir Crit Care Med. 2009 Oct 15;180(8):741-50
references.pmid: 19644045
references.citation: Proc Am Thorac Soc. 2007 Oct 1;4(7):554-64
references.pmid: 17878469
references.citation: N Engl J Med. 1975 Mar 13;292(11):563-71
references.pmid: 802896
references.citation: Am J Respir Crit Care Med. 1998 May;157(5 Pt 1):1418-22
references.pmid: 9603117
references.citation: Cochrane Database Syst Rev. 2011 May 11;(5):CD002309
references.pmid: 21563134
references.citation: Expert Opin Investig Drugs. 2008 May;17(5):811-8
references.pmid: 18447606
references.citation: N Engl J Med. 2003 Jun 26;348(26):2618-25
references.pmid: 12826636
references.citation: Am J Respir Crit Care Med. 2011 Mar 1;183(5):675-8
references.pmid: 20889902
references.citation: N Engl J Med. 1999 Jun 24;340(25):1948-53
references.pmid: 10379018
references.citation: Can Respir J. 2007 Nov-Dec;14(8):485-9
references.pmid: 18060094
references.citation: Circulation. 2004 Nov 9;110(19):3149-55
references.pmid: 15533876
references.citation: Am J Respir Crit Care Med. 2006 Apr 15;173(8):842-6
references.pmid: 16439716
references.citation: Am J Respir Crit Care Med. 1996 Oct;154(4 Pt 1):959-67
references.pmid: 8887592
references.citation: N Engl J Med. 2011 Mar 24;364(12):1093-1103
references.pmid: 21428765
references.citation: Can Respir J. 2007 Sep;14 Suppl B:5B-32B
references.pmid: 17885691
references.citation: Pharmacoeconomics. 2007;25(8):695-711
references.pmid: 17640111
references.citation: Immunopharmacology. 2000 May;47(2-3):127-62
references.pmid: 10878287
references.citation: Am J Respir Crit Care Med. 2007 Jul 15;176(2):154-61
references.pmid: 17463412
references.citation: Am J Respir Crit Care Med. 2003 Mar 15;167(6):813-8
references.pmid: 12623857
references.citation: Chest. 2006 Jan;129(1):56-66
references.pmid: 16424413
references.citation: Thorax. 2007 Dec;62(12):1081-7
references.pmid: 17573446
references.citation: Ann Intern Med. 2007 Apr 17;146(8):545-55
references.pmid: 17310045
references.citation: Thorax. 2004 Jul;59(7):574-80
references.pmid: 15223864